Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

    Press Releases | July 5, 2024 | Medscape Education

    Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

    Mobile Flexibility – Perks of Virtual Medical Education

    Videos and Podcasts | July 4, 2024 | Impetus Digital

    Unlock the potential of virtual collaboration with mobile flexibility! Discover how the latest technologies enable you to engage in medical education and collaborate from any corner of the globe. Watch...

    The Importance of LGBTQ Diversity in Healthcare

    Press Releases | July 3, 2024 | Mednet

    We take a look at the importance of ensuring diversity in the Pharma industry

    Surrogate endpoints in HTA: Reflections on my HTAi panel discussion

    Press Releases | July 2, 2024 | Petauri Evidence

    Calum Jones (Associate Director – Health Economics, Mtech Access) shares his experience of speaking at the 2024 HTAi Annual Meeting. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health...

    US and European Market Access for Medical Devices – Free Guide

    White Papers and Resources | July 2, 2024 | Petauri Evidence

    We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...

    Say Goodbye to Costly Delays – Origins’ Clinical Trial Participant Simulations Have the Answer!

    Press Releases | July 2, 2024 | Origins – The Patient Focused Specialists

    Lack of Patient Involvement in Clinical Trial Designs Causes Major Issues Low recruitment and retention of clinical trials is a key issue faced by many clinical trials. These can lead...

    Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

    White Papers and Resources | June 28, 2024 | Amiculum

    By Manca Povsic and Andrew Dobb

    Unrivalled Convenience – Perks of Virtual Medical Education

    Videos and Podcasts | June 27, 2024 | Impetus Digital

    Explore the unrivalled convenience of virtual collaboration in medical education with our new series, "Perks of Virtual Medical Education." Learn why this flexible, efficient mode of learning is the future...

    OPEN Health and fusion announce partnership to deliver AI-powered healthcare communications

    Press Releases | June 24, 2024 | OPEN Health

    OPEN Health, a pre-eminent global provider of scientific communications, HEOR and market access, patient engagement, and consulting, today announced a partnership with fusion, an innovative artificial intelligence (AI) and machine...

    Eyes on the horizon: six (and a half) predictions for the future of healthcare communications

    White Papers and Resources | June 21, 2024 | Amiculum

    By Zoë van Helmond and Leyna Prince